Auron Therapeutics

CHARM Therapeutics

This company develops small-molecule drugs for cancer patients using a deep-learning platform that models protein-ligand interactions to identify novel therapeutic targets.

Deepcure

This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.

Iambic

This company develops small molecule medicines for patients with cancer using an artificial intelligence drug discovery platform.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.

Allorion

This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.

Orogen Therapeutics

Orogen Therapeutics develops small-molecule drugs for autoimmune and immuno-inflammatory diseases using an AI-enabled DNA-encoded library platform to identify novel chemical matter for patients.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Auransa

This biotechnology company develops precision medicines for cancer and other diseases using an artificial intelligence platform to identify novel therapies and patient subgroups.